Regulation of opioid tolerance by let-7 family microRNA targeting the mu opioid receptor - PubMed (original) (raw)
Regulation of opioid tolerance by let-7 family microRNA targeting the mu opioid receptor
Ying He et al. J Neurosci. 2010.
Abstract
MicroRNA has emerged as a critical regulator of neuronal functions. This study aimed to test whether let-7 microRNAs can regulate the mu opioid receptor (MOR) and opioid tolerance. Employing bioinformatics, we identified a let-7 binding site in the 3'-untranslated region (UTR) of MOR mRNA, which was experimentally confirmed as a direct target of let-7. The repressive regulation of MOR by let-7 was revealed using a LNA-let-7 inhibitor to knockdown let-7 in SH-SY5Y cells. Conversely, morphine significantly upregulated let-7 expression in SH-SY5Y cells and in a mouse model of opioid tolerance. The LNA-let-7 inhibitor decreased brain let-7 levels and partially attenuated opioid antinociceptive tolerance in mice. Although chronic morphine treatment did not change overall MOR transcript, polysome-associated mRNA declined in a let-7-dependent manner. let-7 was identified as a mediator translocating and sequestering MOR mRNA to P-bodies, leading to translation repression. These results suggest that let-7 plays an integral role in opioid tolerance.
Figures
Figure 1.
Interaction of let-7 with the 3′-UTR of the MOR. A, Sequence alignment of the let-7 family miRNAs and the predicted sequence pairing with a region of MOR mRNA 3′-UTR. The nucleotides in red are the positions that are identical among all members of the let-7 family. The predicted MOR mRNA 3′-UTR sequences that may interact with let-7 seed match are in green (bold). B, A schematic plot of the luciferase constructs. Solid bar indicates the location of the putative let-7 binding site within the 3′-UTR of MOR mRNA. The LNA-let-7 inhibitor and scrambled-LNA control are shown below the let-7a alignment with the position of LNA nucleotides underlined in bold. C, Luciferase reporter assays were performed in HEK293 cells transfected with the reporter plasmids psiCHECK/MOR1UTR or psiCHECK/MOR1UTRmut together with the LNA-let-7 inhibitor (0, 1, 5, 25 pmol) or scrambled-LNA control (25 pmol). The Renilla luciferase activity was normalized to the internal control firefly luciferase activity. *p < 0.05, ***p < 0.001 vs the 3′-UTR control (n = 3).
Figure 2.
Constitutive repression of MOR expression by let-7 miRNAs in SH-SY5Y cells. SH-SY5Y cells were transfected with the LNA-let-7 inhibitor (0, 2, 10, 50, 250 pmol) or scrambled-LNA control (250 pmol). Cells were lysed for Western blot analysis 48 h later. The anti-MOR antibody did not detect 65 kDa MOR bands in the null deletion mice (supplemental Fig. S1, available at
as supplemental material). Histogram graph was constructed from the representative figure shown and two other experiments. ***p < 0.001 vs the control.
Figure 3.
Increased let-7 expression and decreased MOR expression in SH-SY5Y cells during the development of opioid tolerance. SH-SY5Y cells with or without retinoic acid (RA) pretreatment (5 μ
m
, 6 d) were incubated with morphine (1 μ
m
, 24–48 h) to induce a tolerant state. The transcripts of let-7a (A), let-7c (B), and let-7g (C), but not miR-134 (D), were increased as determined by the real time RT-PCR. MOR expression was decreased as measured by Western blot analysis (E, F). *p < 0.05, **p < 0.01, ***p < 0.001 compared with 0 h without RA; ##p < 0.01, ###p < 0.001 compared with 0 h with RA (n = 3).
Figure 4.
Increased let-7 expression in the mouse brain during the development of opioid tolerance. Mice were implanted with morphine pellets to induce opioid tolerance. On day 0, 1, 3 and 5, brain let-7a (A), let-7c (B), let-7g (C), and miR-134 (D) transcripts were analyzed by quantitative RT-PCR. The development of opioid tolerance was confirmed by following significantly reduced morphine-antinociception in a tail-flick assay (E). *p < 0.05, ***p < 0.001 vs day 0 group (n = 5).
Figure 5.
Fluorescence in situ hybridization (FISH) of let-7 before and after the treatment with morphine (75 mg/pellet/mouse). The brain cortex was used for the analysis of let-7 mRNA by FISH. Samples were costained using anti-MOR antibody (1:5000) to determine the level of let-7 in MOR-expressing cells. The let-7 transcript was increased after morphine treatment. Moreover, the increase was observed in MOR-expressing cells (arrows indicate representative cells with costaining of MOR and let-7), but not in MOR-negative cells (only DAPI nuclear staining, but no MOR staining). Fifteen prefrontal cortex slices from 3 mice were studied for each condition. In the control group, 78 MOR-expressing cells and 60 MOR-negative cells were imaged. In the morphine group, let-7 upregulation occurred in 78/85 MOR-expressing cells; no cell showed let-7 response in MOR-negative cells (0/65).
Figure 6.
Effect of the LNA-let-7 inhibitor on morphine antinociception, morphine antinociceptive tolerance, and let-7 expression in mice. A, The LNA-let-7 inhibitor potentiated morphine antinociception in naive mice, suggesting constitutive repression of MOR by let-7. B, The LNA-let-7 inhibitor dose-dependently attenuated morphine antinociceptive tolerance. C–E, Morphine-induced let-7 upregulation was dose-dependently reduced by the LNA-let-7 inhibitor (0.3–3.0 nmol, twice/day, for 3 d). *p < 0.05, **p < 0.01, ***p < 0.001 vs the control group; #p < 0.05, ##p < 0.01, ###p < 0.001 vs the morphine group (n = 4).
Figure 7.
The total and polysome-associated μ opioid receptor transcript after the treatment with morphine in SH-SY5Y cells. SH-SY5Y cells were treated with morphine (1 μ
m
, 48 h). A, MOR transcript was not altered by morphine (n = 5 each group). B, Polysome-associated MOR mRNA was decreased by morphine. The change was significantly attenuated by the LNA-let-7 inhibitor. **p < 0.01 vs the control group; #p < 0.05, vs the morphine group (n = 5 each group). C, Colocalization of MOR mRNA with hDcp1a, a P-body marker, after, but not before, morphine treatment. Blue (DAPI) identifies nuclei.
Figure 8.
A schematic plot for the proposed mechanism of MOR regulation by let-7. Pri- and pre-let-7 were produced and exported into the cytosol where the mature let-7 was incorporated into the RISC. The latter recruits and sequesters MOR mRNA to P-bodies that are deprived of translational machinery, effectively reducing polysome-bound MOR mRNA and leading to translation repression.
Similar articles
- Morphine modulates the expression of mu-opioid receptor exon 5-associated full-length C-terminal splice variants by upregulating miR-378a-3p.
Lu Z, Xu J, Wang Q, Pan YX. Lu Z, et al. FASEB J. 2020 Mar;34(3):4540-4556. doi: 10.1096/fj.201901879RR. Epub 2020 Jan 30. FASEB J. 2020. PMID: 31999011 Free PMC article. - MicroRNA 339 down-regulates μ-opioid receptor at the post-transcriptional level in response to opioid treatment.
Wu Q, Hwang CK, Zheng H, Wagley Y, Lin HY, Kim DK, Law PY, Loh HH, Wei LN. Wu Q, et al. FASEB J. 2013 Feb;27(2):522-35. doi: 10.1096/fj.12-213439. Epub 2012 Oct 19. FASEB J. 2013. PMID: 23085997 Free PMC article. - Long-term morphine treatment decreases the association of mu-opioid receptor (MOR1) mRNA with polysomes through miRNA23b.
Wu Q, Zhang L, Law PY, Wei LN, Loh HH. Wu Q, et al. Mol Pharmacol. 2009 Apr;75(4):744-50. doi: 10.1124/mol.108.053462. Epub 2009 Jan 14. Mol Pharmacol. 2009. PMID: 19144786 Free PMC article. - Direct association of Mu-opioid and NMDA glutamate receptors supports their cross-regulation: molecular implications for opioid tolerance.
Garzón J, Rodríguez-Muñoz M, Sánchez-Blázquez P. Garzón J, et al. Curr Drug Abuse Rev. 2012 Sep;5(3):199-226. doi: 10.2174/1874473711205030199. Curr Drug Abuse Rev. 2012. PMID: 22920535 Review. - The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence.
Bao Y, Gao Y, Yang L, Kong X, Yu J, Hou W, Hua B. Bao Y, et al. Channels (Austin). 2015;9(5):235-43. doi: 10.1080/19336950.2015.1069450. Epub 2015 Jul 15. Channels (Austin). 2015. PMID: 26176938 Free PMC article. Review.
Cited by
- Epigenetic regulation in opioid induced hyperalgesia.
Reddy D, Wickman JR, Ajit SK. Reddy D, et al. Neurobiol Pain. 2023 Nov 23;14:100146. doi: 10.1016/j.ynpai.2023.100146. eCollection 2023 Aug-Dec. Neurobiol Pain. 2023. PMID: 38099284 Free PMC article. Review. - miRNAs and Substances Abuse: Clinical and Forensic Pathological Implications: A Systematic Review.
Occhipinti C, La Russa R, Iacoponi N, Lazzari J, Costantino A, Di Fazio N, Del Duca F, Maiese A, Fineschi V. Occhipinti C, et al. Int J Mol Sci. 2023 Dec 4;24(23):17122. doi: 10.3390/ijms242317122. Int J Mol Sci. 2023. PMID: 38069445 Free PMC article. Review. - Spinal microRNA-134-5p targets glutamate receptor ionotropic kainate 3 to modulate opioid induced hyperalgesia in mice.
Wang Z, Yao Y, Tao Y, Fan P, Yu Y, Xie K, Wang G. Wang Z, et al. Mol Pain. 2023 Jan-Dec;19:17448069231178271. doi: 10.1177/17448069231178271. Mol Pain. 2023. PMID: 37247385 Free PMC article. - MiR-33-5p Regulates CREB to Induce Morphine State-dependent Memory in Rats: Interaction with the µ Opioid Receptor.
Moradi Vastegani S, Alani B, Kharazmi K, Ardjmand A. Moradi Vastegani S, et al. Int J Mol Cell Med. 2022;11(2):150-167. doi: 10.22088/IJMCM.BUMS.11.2.150. Epub 2023 Feb 1. Int J Mol Cell Med. 2022. PMID: 37091037 Free PMC article. - Genetic and epigenetic studies of opioid abuse disorder - the potential for future diagnostics.
Abdulmalek S, Hardiman G. Abdulmalek S, et al. Expert Rev Mol Diagn. 2023 May;23(5):361-373. doi: 10.1080/14737159.2023.2190022. Epub 2023 Apr 20. Expert Rev Mol Diagn. 2023. PMID: 37078260 Free PMC article. Review.
References
- Ambros V. The functions of animal microRNAs. Nature. 2004;431:350–355. - PubMed
- Bernstein MA, Welch SP. mu-Opioid receptor down-regulation and cAMP-dependent protein kinase phosphorylation in a mouse model of chronic morphine tolerance. Brain Res Mol Brain Res. 1998;55:237–242. - PubMed
- Bhargava HN, Gulati A. Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats. Eur J Pharmacol. 1990;190:305–311. - PubMed
- Bhattacharyya SN, Habermacher R, Martine U, Closs EI, Filipowicz W. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell. 2006;125:1111–1124. - PubMed
- Boyerinas B, Park SM, Shomron N, Hedegaard MM, Vinther J, Andersen JS, Feig C, Xu J, Burge CB, Peter ME. Identification of let-7-regulated oncofetal genes. Cancer Res. 2008;68:2587–2591. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- GM070388/GM/NIGMS NIH HHS/United States
- R01 HL098141-01/HL/NHLBI NIH HHS/United States
- R01 HL098141/HL/NHLBI NIH HHS/United States
- K07 AT003647/AT/NCCIH NIH HHS/United States
- K07 AT003647-03/AT/NCCIH NIH HHS/United States
- T32 GM070388/GM/NIGMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Research Materials